Approval · Notice of Compliance 14482 · 2013
KIVEXA: Notice of Compliance 14482
Issued June 21, 2013
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 14482
- Date
- June 21, 2013
- Company
- Viiv Healthcare UlcMontreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative transfer of Drug Identification Number
- Therapeutic class
- Antiretroviral agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| KIVEXA | 02269341 | Cancelled Post Market |
Medicinal ingredients
- LAMIVUDINE 300 MG per TAB
- ABACAVIR SULFATE 600 MG per TAB